Side Effects of Temozolomide in Brain Tumor Care
Original title: Multifaceted Temozolomide Toxicity in Glioma: Detection & Care.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This drug is already part of care today, but this was just a small look back at records.
The short version
Most side effects from the brain tumor drug temozolomide got better with care.
What was studied. Doctors at one hospital in Mangalore, India looked back at the records of 38 people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary who took temozolomide by mouth. They counted the side effects and looked at how each one was handled.
What they found. In all, 38 side effects were recorded. The most common were low white blood cell counts (9.3%) and itching (9.3%). Skin reactions usually went away in 4-14 days, but low blood counts took 22-75 days to get better.
What this means, and what it doesn't
What it could mean: Side effects from this drug are common, but they can often be managed. Most people in this study got better without a hospital stay. The death rate was low (5.3%). Your care team can pause the drug, lower the dose, or treat the symptom itself.
What it doesn't mean: This does not mean the drug is safe for everyone, and it is not a promise of a cure. It was a small look back at old records from 38 people at one hospital. It was not a trial, and it says nothing about how well the drug fights the tumor. Your own side effects may be different, so talk with your care team.
Source: PubMed, January 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.